The audiocast explores how AI and ML can impact regulatory drug development, enhancing efficiency, accuracy, and consistency. While challenges like data silos exist, AI is expected to revolutionize drug development without causing significant job loss. Explainable AI and benchmarking play crucial roles in this process.